PART1 and hepatocellular carcinoma: In Huh7 cells, the IC50 values of sorafenib was 7.322 μM and 6.739 μM in the siRNA NC group and si-PART1 groups, respectively (Figure 8D), suggesting that downregulation of PART1 expression increases the sensitivity of HCC cells to sorafenib.